Drug Type Small molecule drug |
Synonyms PF 06256142, PF06256142 |
Target |
Action agonists |
Mechanism D1 receptor agonists(Dopamine D1 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H16N4O2 |
InChIKeyHWAIAGZSWHOLLK-UHFFFAOYSA-N |
CAS Registry1609583-14-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | United States | 27 Dec 2018 | |
Schizophrenia | Preclinical | United States | 27 Dec 2018 |